## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 2.5% below STRENGTH zone (3.0-6.0%); PEG 1.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($449.07)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Lockheed Martin Stock Falls 6% in Six Months: What Should You Do?**
- Source: Finviz | 20251208T141641 | Neutral | Relevance: 98%
- Lockheed Martin's shares have underperformed the Zacks Aerospace-Defense industry over the past six months, declining 6% due to skilled labor shortages and losses on fixed-price programs. Despite these challenges, the company boasts a strong backlog of $179.1 billion from major contract wins, supported by growth in key programs and strategic investments in hypersonics and advanced simulation. While new investors might consider waiting for a better entry point, current holders could retain the stock given its earnings growth projections and superior return on invested capital.

**2. Lockheed Martin Corp -On Dec 5 Entered Into New 364-Day Revolving Credit Agreement - SEC Filing**
- Source: TradingView | 20251209T224620 | Somewhat-Bullish | Relevance: 98%
-  Lockheed Martin Corp (LMT) announced it has entered into a new 364-day revolving credit agreement on December 5. This agreement includes a $3.0 billion unsecured revolving credit facility and is set to mature on December 4, 2026, with an option for a term loan.

**3. Hensoldt partners with Lockheed Martin for German naval systems**
- Source: Investing.com | 20251209T090855 | Bullish | Relevance: 98%
- Hensoldt will act as Lockheed Martin Canada’s German-based contractor to integrate the CMS 330 combat management system into German naval platforms, with work commencing in early 2026. This system aims to boost the capabilities of German naval vessels by enhancing real-time situational awareness and coordinated decision-making. The partnership underscores a strategic collaboration to improve operational effectiveness through advanced technological integration.

**4. Lockheed Martin Wins $1.141B Navy Contract to Advance 198 F-35s Into Production**
- Source: Security Clearance Jobs | 20251208T150813 | Bullish | Relevance: 98%
-  Lockheed Martin Aeronautics Co. has been awarded a $1.141 billion modification to a previously awarded contract. This funding will procure long lead materials, parts, and components for 65 Lot 20 and 133 Lot 21 F-35 production aircraft for the Air Force, Navy, Marine Corps, F-35 cooperative program partners, and Foreign Military Sales customers. The work is expected to be completed by December 2030, with various fiscal year funds being obligated at the time of award.

**5. StoneX Group Inc. Has $1.91 Million Position in Lockheed Martin Corporation $LMT**
- Source: MarketBeat | 20251207T123445 | Neutral | Relevance: 98%
-  StoneX Group Inc. significantly reduced its stake in Lockheed Martin Corporation by 53.2% in Q2, leaving it with 4,121 shares valued at $1.91 million. Concurrently, Lockheed Martin's COO sold a substantial portion of his shares, while the company reported strong Q3 earnings, raised its dividend, and provided optimistic FY2025 guidance. Institutional ownership in the aerospace firm remains high at 74.19%, with several major hedge funds adjusting their positions.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Momentum building: MRS_10 improving +6.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.54 elevated, pricing in significant growth expectations. Forward P/E 16.0x attractive for 30% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $109.0B |
| Beta | 0.24 |
| 52W Range | $410.11 - $516.00 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.54 |
| Forward P/E | 16.0 |
| Current P/E | 20.9 |
| YoY Growth | 30.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -3.7% to 2.5% (+6.2% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.5pp (needs >3.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Outperforming sector by 4.0pp, stock-specific strength. MACD histogram positive (2.03), confirming momentum. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.54% (CS: 80) | Neutral |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | 2.03 | Bullish |
| vs SMA20 | 1.020x | Above |
| vs SMA50 | 0.976x | Below |
| vs SMA200 | 1.005x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $466.89
- **Stop Loss:** $449.07 (3.8% risk)
- **Target:** $484.71 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 28
- **Position Value:** $13,072.92
- **Portfolio %:** 13.07%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*